Wednesday, October 04, 2017 11:14:36 AM
I don't think that they will release anything that is materially significant during a presentation. At least that's how the rules are written for US companies. Providing those who attend a conference like that with new information that could significantly affect the share price would give them an unfair advantage. All significant information has to be made public for everyone at the same time.
I do however expect them to make some public statement about the commencement of the trial. Especially since there has been delays. Healios has to inform their investors to let them know that everything is back on track.
They could wait until they have the first enrollment.
After that we should have a revised estimate for the results of the primary endpoint based on the progress of enrollment. Their CEO mentioned that he planed to do an update during his ER presentation.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM